An Open Label, Randomized, Single Dose, Two-Way Crossover Bioequivalence Study Comparing A Pediatric Appropriate Formulation To A 10 Mg Commercial Atorvastatin Calcium Tablet Formulation In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 21 Dec 2008
At a glance
- Drugs Atorvastatin (Primary)
- Indications Lipid metabolism disorders
- Focus Pharmacokinetics
- Sponsors Pfizer
- 21 Dec 2008 Actual initiation date (Nov 2008) added as reported by ClinicalTrials.gov.
- 20 Nov 2008 Status changed from not yet recruiting to recruiting, as reported in ClinicalTrilas.gov record.
- 14 Nov 2008 New trial record.